Niquitin (Nicotine)

Nicotine, the active ingredient in Niquitin, is a nicotinic receptor agonist presented as a transdermal patch for transdermal use. It treats nicotine dependence and aids smoking cessation in adult smokers, helping to alleviate withdrawal symptoms and reduce cravings. Niquitin is marketed in the European Union as an over‑the‑counter product and is supplied in a ready‑to‑apply patch format.

GNH USA supplies Niquitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Niquitin is a nicotine replacement therapy that acts on the nicotinic acetylcholine receptor system to support cessation of tobacco use. - Smoking cessation: helps adult smokers quit by reducing withdrawal symptoms and cravings. - Nicotine dependence: alleviates physiological dependence on nicotine. - Relapse prevention: supports maintenance of abstinence after quitting.

Niquitin may cause a range of adverse reactions, most of which are related to the transdermal delivery system or systemic nicotine exposure.

Common Side Effects: - Skin irritation at the application site - Itching or redness where the patch is applied - Sleep disturbance or vivid dreams - Nausea or upset stomach - Headache - Dizziness

Serious or Rare Side Effects: - Severe allergic reaction (e.g., rash, swelling, hives) - Significant hypotension or fainting - Chest pain or palpitations - Severe skin rash or blistering - Respiratory difficulty - Unexplained syncope

When using Niquitin, certain precautions should be observed to ensure safety and effectiveness. - Cardiovascular assessment: evaluate patients with recent heart disease before initiating therapy. - Non‑smoker use: avoid prescribing to individuals who do not currently smoke. - Skin condition: do not apply to damaged, irritated, or infected skin. - Children: keep patches out of reach of children and pets. - Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight, and store below 25 °C.

Niquitin can interact with several medication classes; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Certain antihypertensive agents: additive blood pressure lowering effects. - Beta‑blockers: may exacerbate bradycardia or hypotension.

Moderate Interactions (Monitor Closely): - Caffeine: potential for increased nervousness or insomnia. - Alcohol: may enhance nicotine’s cardiovascular effects. - Some antidepressants (e.g., SSRIs): monitor for altered nicotine metabolism.